Scientists at VCU Massey Comprehensive Cancer Center have identified an innovative combination of treatment strategies that ...

Slow the Spread. In the mouse brain, phospho-synuclein pathology (green) accumulates (top) in, from left to right, the motor ...

Discover how next-generation kinase inhibitors are transforming clinical therapy byovercoming resistance and enhancing ...

Healx has dosed the first patient in a Phase II trial assessing its lead pipeline candidate HLX-1502 in patients with neurofibromatosis type 1 (NF1), while the FDA approved SpringWorks Therapeutics’ ...

Nimbus Therapeutics, LLC, a biotechnology company that designs and develops medicines leveraging its computational drug discovery engine, has achieved a significant preclinical milestone under its ...

In collaborative work, Trethera and the Peter Clark Lab at UCLA have shown that when autoreactive T and B cells divide, they ...

A new review published in Genes & Diseases explores the multifaceted role of FAM20C, a Golgi protein kinase, in disease progression.

A new review published in Genes & Diseases explores the multifaceted role of FAM20C, a Golgi protein kinase, in disease ...

BYU Professor David Thomson is working to understand a chemical pathway in human muscles that may explain the effects of exercise.

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

The intestinal epithelium is a highly dynamic barrier that regulates digestion, absorption, immune responses, and ...